SUPN

APOKYN® (apomorphine hydrochloride injection)

Advanced Parkinson’s disease (PD)

Quarterly Sales (Approved)

Exp Date

February 12, 2021 (Est)

Amp Volatility Score

N/A

Catalyst Info & Data Links

TITLE: APOKYN® in Parkinson’s disease - Quarterly Sales (Approved)


WHAT IS THE NEXT CATALYST EVENT?

  • Quarterly Sales (Approved)


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?


PRIOR DATA

PRESS RELEASES

MECHANISM OF ACTION

  • APOKYN is a non-ergoline dopamine agonist with high in vitro binding affinity for the dopamine D4 receptor, and moderate affinity for the dopamine D2, D3, and D5, and adrenergic α1D, α2B, α2C receptors. The precise mechanism of action of APOKYN as a treatment for Parkinson’s disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the caudate-putamen in the brain (Learn more HERE).

MARKET

  • Nearly one million will be living with Parkinson's disease (PD) in the U.S. by 2020, which is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy and Lou Gehrig's disease (or Amyotrophic Lateral Sclerosis)

  • Approximately 60,000 Americans are diagnosed with PD each year.

  • More than 10 million people worldwide are living with PD.

  • Incidence of Parkinson’s disease increases with age, but an estimated four percent of people with PD are diagnosed before age 50.

  • Men are 1.5 times more likely to have Parkinson's disease than women.

  • Learn more at Parkinson's Foundation

Updated by HC

#SUPN, #APOKYN, #Apomorphine hydrochloride injection, #Advanced Parkinson’s disease, #neurology, #brain

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon